Aquestive Therapeutics (AQST) News Today $4.01 +0.23 (+6.08%) Closing price 04:00 PM EasternExtended Trading$4.00 0.00 (-0.12%) As of 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AQST Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Aquestive Therapeutics, Inc.: Aquestive Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business UpdateAugust 13 at 2:59 AM | finanznachrichten.deAquestive Therapeutics (NASDAQ:AQST) Announces Quarterly Earnings ResultsAugust 12 at 6:41 PM | marketbeat.comAquestive Therapeutics, Inc. (AQST) Q2 2025 Earnings Call TranscriptAugust 12 at 10:34 AM | seekingalpha.comAquestive Therapeutics: Q2 Earnings SnapshotAugust 11 at 10:41 PM | chron.comAquestive Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business UpdateAugust 11 at 4:01 PM | globenewswire.comAquestive Therapeutics Inc (AQST) Q2 2025: Everything You Need To Know Ahead Of EarningsAugust 11 at 11:54 AM | finance.yahoo.comAquestive Therapeutics Inc (AQST) Q2 2025 Earnings Report Preview: What To ExpectAugust 9, 2025 | finance.yahoo.comUncovering Potential: Aquestive Therapeutics's Earnings PreviewAugust 8, 2025 | benzinga.comAquestive Therapeutics Q2 2025 Earnings PreviewAugust 8, 2025 | msn.comBrokerages Set Aquestive Therapeutics, Inc. (NASDAQ:AQST) PT at $10.14August 6, 2025 | americanbankingnews.comAquestive Therapeutics, Inc. (NASDAQ:AQST) Given Consensus Recommendation of "Buy" by BrokeragesAugust 3, 2025 | marketbeat.comAquestive Therapeutics Faces Potential Risks with ‘5050Item’: What Investors Need to KnowAugust 1, 2025 | tipranks.comAquestive Therapeutics (AQST) to Release Quarterly Earnings on TuesdayJuly 30, 2025 | marketbeat.comDauntless Investment Group LLC Purchases Shares of 91,540 Aquestive Therapeutics, Inc. (NASDAQ:AQST)July 29, 2025 | marketbeat.comAquestive Therapeutics, Inc.: Aquestive Therapeutics Names Sherry Korczynski as Chief Commercial OfficerJuly 23, 2025 | finanznachrichten.deAquestive Therapeutics Names Sherry Korczynski as Chief Commercial OfficerJuly 22, 2025 | globenewswire.comAquestive Therapeutics Provides International Expansion Update for Anaphylmâ„¢ (epinephrine) Sublingual FilmJuly 15, 2025 | globenewswire.comAquestive Therapeutics, Inc. (NASDAQ:AQST) Shares Acquired by Harvey Capital Management Inc.July 9, 2025 | marketbeat.comAquestive Therapeutics, Inc. (NASDAQ:AQST) Receives Average Rating of "Buy" from AnalystsJuly 9, 2025 | marketbeat.comAquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and MetabolismJuly 7, 2025 | globenewswire.comInstitutional investors are Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) biggest bettors and were rewarded after last week's US$47m market cap gainJuly 6, 2025 | finance.yahoo.comAquestive Therapeutics, Inc. Common Stock (AQST) - NasdaqJuly 5, 2025 | nasdaq.comAquestive Therapeutics Inc News (AQST) - Investing.comJuly 5, 2025 | investing.comH.C. Wainwright Reaffirms Buy on Aquestive Therapeutics, Inc. (AQST) After FDA ApprovalJuly 4, 2025 | finance.yahoo.comAQST - Aquestive Therapeutics Inc Key Metrics - MorningstarJuly 3, 2025 | morningstar.comMH.C. Wainwright Reaffirms Buy on Aquestive Therapeutics, Inc. (AQST) After FDA ApprovalJuly 2, 2025 | insidermonkey.comAquestive Therapeutics Inc (AQST) - Investing.comJuly 2, 2025 | investing.comAquestive Therapeutics: Updating The Anaphylm Timeline To ApprovalJune 25, 2025 | seekingalpha.comAQST | Aquestive Therapeutics Inc. Annual Cash Flow Statement - MarketWatchJune 25, 2025 | marketwatch.comAquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm™ (epinephrine) Sublingual Film at the CFAAR Food Allergy SummitJune 25, 2025 | globenewswire.comAquestive Therapeutics (NASDAQ:AQST) Earns Buy Rating from HC WainwrightJune 17, 2025 | marketbeat.comAquestive Therapeutics Announces FDA Acceptance of New Drug Application and PDUFA Date for Anaphylm™ for the Treatment of Severe Allergic ReactionsJune 16, 2025 | finance.yahoo.comAquestive Therapeutics, Inc. (NASDAQ:AQST) Given Consensus Rating of "Buy" by AnalystsJune 14, 2025 | marketbeat.comCantor Fitzgerald Predicts AQST FY2026 EarningsJune 11, 2025 | marketbeat.comAquestive Therapeutics: Anaphylm Could Gain Significant Market ShareJune 8, 2025 | seekingalpha.comAquestive Therapeutics (NASDAQ:AQST) Coverage Initiated by Analysts at OppenheimerJune 2, 2025 | marketbeat.comBank of America Corp DE Boosts Stake in Aquestive Therapeutics, Inc. (NASDAQ:AQST)June 2, 2025 | marketbeat.comWoodline Partners LP Reduces Holdings in Aquestive Therapeutics, Inc. (NASDAQ:AQST)May 27, 2025 | marketbeat.comThose who invested in Aquestive Therapeutics (NASDAQ:AQST) three years ago are up 128%May 26, 2025 | finance.yahoo.comAquestive Therapeutics, Inc. (NASDAQ:AQST) Shares Sold by VR Adviser LLCMay 22, 2025 | marketbeat.comAquestive Therapeutics, Inc. (NASDAQ:AQST) Given Average Rating of "Buy" by AnalystsMay 22, 2025 | marketbeat.comAquestive Therapeutics, Inc. (AQST): Analysts See 245% Upside PotentialMay 21, 2025 | insidermonkey.comStonepine Capital Management LLC Acquires New Position in Aquestive Therapeutics, Inc. (NASDAQ:AQST)May 20, 2025 | marketbeat.comQ2 EPS Forecast for Aquestive Therapeutics Cut by AnalystMay 20, 2025 | marketbeat.comMPM Bioimpact LLC Has $5.74 Million Stock Position in Aquestive Therapeutics, Inc. (NASDAQ:AQST)May 16, 2025 | marketbeat.comAquestive Therapeutics (NASDAQ:AQST) Posts Quarterly Earnings Results, Misses Expectations By $0.07 EPSMay 14, 2025 | marketbeat.comAquestive Therapeutics Inc (AQST) Q1 2025 Earnings Call Highlights: Navigating Revenue Declines ...May 14, 2025 | finance.yahoo.comAquestive Therapeutics’ Q1 2025: Focus on AnaphylmMay 13, 2025 | tipranks.comEarnings To Watch: Aquestive Therapeutics Inc (AQST) Reports Q1 2025 ResultMay 13, 2025 | finance.yahoo.comAquestive Therapeutics' Shares Fall to 52-Week Low on 1Q Results, Outlook CutMay 13, 2025 | marketwatch.com Get Aquestive Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AQST and its competitors with MarketBeat's FREE daily newsletter. Email Address AQST Media Mentions By Week AQST Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AQST News Sentiment▼0.410.71▲Average Medical News Sentiment AQST News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AQST Articles This Week▼123▲AQST Articles Average Week Get Aquestive Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AQST and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TWST News TVTX News BHVN News AUPH News SDGR News EVO News JANX News ETNB News EWTX News WVE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AQST) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aquestive Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aquestive Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access